anmelden
OMX Nordic 40
2.711,69
PKT
-3,84
PKT
-0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.09.21 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 02.09.21 | Volvo (B) Sell | UBS AG | |
| 02.09.21 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.09.21 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.09.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 01.09.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.08.21 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 26.08.21 | Novo Nordisk Neutral | UBS AG | |
| 26.08.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.08.21 | Hennes Mauritz (H M, H&M) Overweight | JP Morgan Chase & Co. | |
| 25.08.21 | Volvo (B) Sell | UBS AG | |
| 25.08.21 | Kone Sell | UBS AG | |
| 25.08.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 25.08.21 | Hennes Mauritz (H M, H&M) Sell | Deutsche Bank AG | |
| 23.08.21 | Kone Underperform | Jefferies & Company Inc. | |
| 23.08.21 | AstraZeneca Buy | UBS AG | |
| 23.08.21 | Novo Nordisk Neutral | Credit Suisse Group | |
| 20.08.21 | Novo Nordisk Outperform | Bernstein Research | |
| 17.08.21 | Novo Nordisk Neutral | UBS AG | |
| 17.08.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.08.21 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.08.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 16.08.21 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. | |
| 12.08.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.08.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.08.21 | AstraZeneca Buy | UBS AG | |
| 06.08.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.08.21 | Novo Nordisk Outperform | Bernstein Research | |
| 06.08.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.08.21 | Novo Nordisk Overweight | Barclays Capital | |
| 05.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.08.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.08.21 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.08.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.07.21 | A.P. Moeller - Maersk A-S (B) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.07.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.07.21 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group |
